about
Glycans - the third revolution in evolution.Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination StrategiesStructural and functional characterization of the trifunctional antibody catumaxomabTreatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin GInflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese populationBispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.The role of glycosylation in IBD.Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis.Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma.Fully Automated Sample Preparation for Ultrafast N-Glycosylation Analysis of Antibody Therapeutics.
P2860
Q30363360-8C3D37E0-C4EA-4472-9D22-7133BDEEEAFBQ30408097-F614C819-46E3-44E3-BE3E-85705E14452DQ34619043-A30C3306-ABBE-45B8-86C6-C1F5A717FFB7Q35063963-DC141D90-12AB-46AF-8C3D-BE07078583ECQ35670608-F030113E-7B55-4253-BE8E-1189DECCDC59Q37116784-CCD64069-AB53-4963-969C-60C3FE5471F7Q38074885-CCFA375E-DB3F-4F8D-B144-9E2650A65736Q38218832-6A4E04F2-1CDB-4BB7-B216-3101F8BE93EBQ38828582-7711CB3A-D467-42E3-90B3-A518EAADEBC6Q50138178-CC609EFC-0C20-438D-B394-FD3A39FF58FFQ50540781-FBDD137A-44E4-4E71-B271-12816F3E4C4BQ51699743-B7B2F62F-1654-4E29-9532-6322E3E301E6
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Making autoantibodies safe
@ast
Making autoantibodies safe
@en
type
label
Making autoantibodies safe
@ast
Making autoantibodies safe
@en
prefLabel
Making autoantibodies safe
@ast
Making autoantibodies safe
@en
P2093
P2860
P356
P1476
Making autoantibodies safe
@en
P2093
Christopher N Scanlan
Dennis R Burton
Raymond A Dwek
P2860
P304
P356
10.1073/PNAS.0801192105
P407
P577
2008-03-14T00:00:00Z